Optimization and validation of a reporter gene assay for screening of phosphodiesterase inhibitors in a high throughput system
Authors:
- 17 October 2008
- journal article
- technical report
- Published by Wiley in Biotechnology Journal
- Vol. 3 (9-10) , 1276-1279
Abstract
Phosphodiesterases (PDEs) hydrolyze cyclic nucleotides, cyclic adenosine monophosphate (cAMP) and guanosine monophosphate (cGMP) into inactive 5' monophosphates, and exist as 11 families. Inhibitors of PDEs allow the elevation of cAMP and cGMP, which leads to a variety of cellular effects including airway smooth muscle relaxation and inhibition of cellular inflammation or of immune responses. PDE4 inhibitors specifically prevent the hydrolysis of cAMP. We have validated the manually developed reporter gene assay in a high‐throughput screening format that allows for fast and cost‐effective identification of potential inhibitors of PDE4 isozymes. The assay is sensitive and robust, with a Z' value of >0.5. The assay is also amenable to 384‐well format.Keywords
This publication has 7 references indexed in Scilit:
- A reporter gene assay for screening of PDE4 subtype selective inhibitorsBiochemical and Biophysical Research Communications, 2007
- Cyclic nucleotide phosphodiesterase (PDE) superfamily: A new target for the development of specific therapeutic agentsPharmacology & Therapeutics, 2006
- PDE4 inhibitors as new anti-inflammatory drugs: Effects on cell trafficking and cell adhesion molecules expressionPharmacology & Therapeutics, 2005
- Recent Advances in PDE4 Inhibitors as Immunoregulators and Anti- Inflammatory DrugsCurrent Pharmaceutical Design, 2002
- Regulation of cAMP‐specific phosphodiesterases type 4B and 4D (PDE4) splice variants by cAMP signaling in primary cortical neuronsJournal of Neurochemistry, 2002
- A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening AssaysSLAS Discovery, 1999
- Cyclic nucleotide phosphodiesterases: functional implications of multiple isoformsPhysiological Reviews, 1995